T

Tarsus Pharmaceuticals, Inc.

345 employees

Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.

Investor insights

Funding rounds participated in

$125M sweet spot round size

Investor type

Public Company

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Date founded

2017

Funding rounds raised

Total raised

$125M

from investors over 1 rounds

T

Tarsus Pharmaceuticals, Inc. raised $125M on April 12, 2025